BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: VanWagner LB, Harinstein ME, Runo JR, Darling C, Serper M, Hall S, Kobashigawa JA, Hammel LL. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations. Am J Transplant 2018;18:30-42. [PMID: 28985025 DOI: 10.1111/ajt.14531] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Crespo G. Moving Forward in the Stratification of Cardiac Risk in Liver Transplantation Candidates. Liver Transpl 2021;27:957-8. [PMID: 33550711 DOI: 10.1002/lt.26005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Nayagam JS, Norton BC, Belete S, Rosinhas J, Ramos K, Cramp ME, O'kane R, Cash WJ, Milan Z, Nicholson C, Menon K, Prachalias A, Srinivasan P, Auzinger G, Byrne J, Maccarthy PA, Melikian N, Agarwal K, Aluvihare VR, Joshi D, Heneghan MA. Invasive coronary angiography as a tool in cardiac evaluation for liver transplant candidates. Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100100] [Reference Citation Analysis]
3 Welch N, Attaway A, Bellar A, Alkhafaji H, Vural A, Dasarathy S. Compound Sarcopenia in Hospitalized Patients with Cirrhosis Worsens Outcomes with Increasing Age. Nutrients 2021;13:659. [PMID: 33670535 DOI: 10.3390/nu13020659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Parente A, Ronca V. Assessment of advanced age candidates for liver transplantation warrants more caution. World J Transplant 2022; 12(2): 24-26 [DOI: 10.5500/wjt.v12.i2.24] [Reference Citation Analysis]
5 Markin NW, Ringenberg KJ, Kassel CA, Walcutt CR, Chacon MM. 2018 Clinical Update in Liver Transplantation. Journal of Cardiothoracic and Vascular Anesthesia 2019;33:3239-48. [DOI: 10.1053/j.jvca.2019.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
6 Bonou M, Mavrogeni S, Kapelios CJ, Skouloudi M, Aggeli C, Cholongitas E, Papatheodoridis G, Barbetseas J. Preoperative Evaluation of Coronary Artery Disease in Liver Transplant Candidates: Many Unanswered Questions in Clinical Practice. Diagnostics (Basel) 2021;11:75. [PMID: 33466478 DOI: 10.3390/diagnostics11010075] [Reference Citation Analysis]
7 Xiao J, Yong JN, Ng CH, Syn N, Lim WH, Tan DJH, Tan EY, Huang D, Wong RC, Chew NWS, Tan EXX, Noureddin M, Siddiqui MS, Muthiah MD. A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients. Liver Transpl 2021. [PMID: 34626045 DOI: 10.1002/lt.26331] [Reference Citation Analysis]
8 Koshy AN, Gow PJ, Han HC, Teh AW, Jones R, Testro A, Lim HS, McCaughan G, Jeffrey GP, Crawford M, Macdonald G, Fawcett J, Wigg A, Chen JWC, Gane EJ, Munn SR, Clark DJ, Yudi MB, Farouque O. Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years. Eur Heart J Qual Care Clin Outcomes 2020;6:243-53. [PMID: 32011663 DOI: 10.1093/ehjqcco/qcaa009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
9 Zerillo J, Smith NK, Sakai T. Noteworthy Literature published in 2017 for Abdominal Organ Transplantation. Semin Cardiothorac Vasc Anesth 2018;22:67-80. [PMID: 29400258 DOI: 10.1177/1089253217753399] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Goldberg D, Mantero A, Newcomb C, Delgado C, Forde K, Kaplan D, John B, Nuchovich N, Dominguez B, Emanuel E, Reese PP. Development and Validation of a Model to Predict Long-Term Survival After Liver Transplantation. Liver Transpl 2021;27:797-807. [PMID: 33540489 DOI: 10.1002/lt.26002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Buggs J, Aslam S, Walker C, Hook M, M. Matyja T, Rogers E, Nyce S, Patiño D, Kumar A, Kemmer N. Pre-Liver Transplant Coronary Artery Disease Workup for Low-Risk Patients. The American Surgeon 2020;86:976-80. [DOI: 10.1177/0003134820942169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Desjardin JT, Manicardi M, Svetlichnaya Y, Kolaitis NA, Papolos AI, Selby VN, Zier LS, Klein L, Aras MA, Yao FY, Roberts JP, De Marco T. Noninvasive estimation of pulmonary vascular resistance improves portopulmonary hypertension screening in liver transplant candidates. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
13 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
14 Rachwan RJ, Kutkut I, Timsina LR, Bou Chaaya RG, El-Am EA, Sabra M, Mshelbwala FS, Rahal MA, Lacerda MA, Kubal CA, Fridell JA, Ghabril MS, Bourdillon PD, Mangus RS. CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates. J Hepatol 2021;75:142-9. [PMID: 33476745 DOI: 10.1016/j.jhep.2021.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Dave S, Barnard A, Mendler M. CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient. Clin Liver Dis (Hoboken) 2021;17:37-40. [PMID: 33552485 DOI: 10.1002/cld.966] [Reference Citation Analysis]
16 Moon YJ, Kwon HM, Jung KW, Kim KS, Shin WJ, Jun IG, Song JG, Hwang GS. Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation. Korean J Anesthesiol 2021;74:242-53. [PMID: 32846082 DOI: 10.4097/kja.20296] [Reference Citation Analysis]
17 Mester RA, Stoll WD. Cirrhotic Cardiomyopathy and Cardiac Failure after Liver Transplantation: A Case Series. Transplant Proc 2021;53:2354-7. [PMID: 34417032 DOI: 10.1016/j.transproceed.2021.07.019] [Reference Citation Analysis]
18 Eyvazian VA, Gordin JS, Yang EH, Aksoy O, Honda HM, Busuttil RW, Agopian VG, Vorobiof G. Incidence, Predictors, and Outcomes of New-Onset Left Ventricular Systolic Dysfunction After Orthotopic Liver Transplantation. J Card Fail 2019;25:166-72. [PMID: 30412734 DOI: 10.1016/j.cardfail.2018.10.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. Journal of Hepatology 2019;70:745-58. [DOI: 10.1016/j.jhep.2018.12.009] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 20.7] [Reference Citation Analysis]
20 Park J, Lee J, Kwon A, Choi HJ, Chung HS, Hong SH, Park CS, Choi JH, Chae MS. The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation. PLoS One 2019;14:e0215603. [PMID: 31013321 DOI: 10.1371/journal.pone.0215603] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bernal-reyes R, Castro-narro G, Malé-velázquez R, Carmona-sánchez R, González-huezo M, García-juárez I, Chávez-tapia N, Aguilar-salinas C, Aiza-haddad I, Ballesteros-amozurrutia M, Bosques-padilla F, Castillo-barradas M, Chávez-barrera J, Cisneros-garza L, Flores-calderón J, García-compeán D, Gutiérrez-grobe Y, Higuera de la Tijera M, Kershenobich-stalnikowitz D, Ladrón de Guevara-cetina L, Lizardi-cervera J, López-cossio J, Martínez-vázquez S, Márquez-guillén E, Méndez-sánchez N, Moreno-alcantar R, Poo-ramírez J, Ramos-martínez P, Rodríguez-hernández H, Sánchez-ávila J, Stoopen-rometti M, Torre-delgadillo A, Torres-villalobos G, Trejo-estrada R, Uribe-esquivel M, Velarde-ruiz Velasco J. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019;84:69-99. [DOI: 10.1016/j.rgmxen.2019.02.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Ivanics T, Abreu P, De Martin E, Sapisochin G. Changing Trends in Liver Transplantation: Challenges and Solutions. Transplantation 2021;105:743-56. [PMID: 32910093 DOI: 10.1097/TP.0000000000003454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
23 Moon YJ, Kwon HM, Jung KW, Jeong HW, Park YS, Jun IG, Song JG, Hwang GS. Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease. Am J Transplant 2019;19:2053-66. [PMID: 30653845 DOI: 10.1111/ajt.15263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 McCarthy KJ, Motta-Calderon D, Estrada-Roman A, Cajiao KM, Curry MP, Bonder A, Anagnostopoulos AM, Gavin M. Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant - A retrospective cohort analysis. Ann Hepatol 2021;27:100582. [PMID: 34808392 DOI: 10.1016/j.aohep.2021.100582] [Reference Citation Analysis]
25 Izzy M, VanWagner LB, Lee SS, Altieri M, Angirekula M, Watt KD. Understanding and managing cardiovascular outcomes in liver transplant recipients. Curr Opin Organ Transplant 2019;24:148-55. [PMID: 30676402 DOI: 10.1097/MOT.0000000000000614] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
26 Barman PM, VanWagner LB. Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions. Hepatology 2021;73:2564-76. [PMID: 33219576 DOI: 10.1002/hep.31647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 VanWagner LB. Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark? Liver Transpl 2018;24:865-7. [PMID: 29781097 DOI: 10.1002/lt.25203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Jesudian AB. Improving Perioperative Cardiac Risk Stratification in Liver Transplant: A New Role for Coronary Computed Tomography Angiography? Liver Transpl 2020;26:1389-90. [DOI: 10.1002/lt.25891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Stine JG, Bezinover D, Kadry Z. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transpl 2018;24:976-7. [PMID: 29603562 DOI: 10.1002/lt.25064] [Reference Citation Analysis]
30 Sun X, Qiu W, Chen Y, Lv G, Fan Z. Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report. Medicine (Baltimore) 2018;97:e12407. [PMID: 30213015 DOI: 10.1097/MD.0000000000012407] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Goldberg D, Mantero A, Newcomb C, Delgado C, Forde KA, Kaplan DE, John B, Nuchovich N, Dominguez B, Emanuel E, Reese PP. Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score. J Hepatol. 2021;74:1398-1406. [PMID: 33453328 DOI: 10.1016/j.jhep.2020.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Robertson M, Chung W, Liu D, Seagar R, O'Halloran T, Koshy AN, Horrigan M, Farouque O, Gow P, Angus P. Cardiac Risk Stratification in Liver Transplantation: Results of a Tiered Assessment Protocol Based on Traditional Cardiovascular Risk Factors. Liver Transpl 2021;27:1007-18. [PMID: 33606328 DOI: 10.1002/lt.26025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Kwon H, Moon Y, Jung K, Park Y, Kim K, Jun I, Song J, Hwang G. Appraisal of Cardiac Ejection Fraction With Liver Disease Severity: Implication in Post–Liver Transplantation Mortality. Hepatology 2020;71:1364-80. [DOI: 10.1002/hep.30913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 De Gasperi A, Zorzi A. Cardiac evaluation before liver transplantation: A step forward? J Hepatol 2021;75:19-21. [PMID: 33985819 DOI: 10.1016/j.jhep.2021.04.034] [Reference Citation Analysis]
35 VanWagner LB. A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation score. Clin Liver Dis (Hoboken) 2018;11:145-8. [PMID: 30319773 DOI: 10.1002/cld.718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Maliakkal BJ. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation. Transl Gastroenterol Hepatol 2020;5:36. [PMID: 32632387 DOI: 10.21037/tgh.2019.12.02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kwon HM, Moon YJ, Kim KS, Shin WJ, Huh IY, Jun IG, Song JG, Hwang GS. Prognostic Value of B-Type Natriuretic Peptide in Liver Transplant Patients: Implication in Posttransplant Mortality. Hepatology 2021;74:336-50. [PMID: 33249627 DOI: 10.1002/hep.31661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bhatti S, Lizaola-mayo B, Al-shoha M, Garcia-saenz-de-sicilia M, Habash F, Ayoub K, Karr M, Ahmed Z, Borja-cacho D, Duarte-rojo A. Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.015] [Reference Citation Analysis]
39 Barman PM, Chadha RM, VanWagner LB. Cardiac Risk Assessment in Liver Transplant Candidates: A Survey of National Practice Patterns. Liver Transpl 2021. [PMID: 34536331 DOI: 10.1002/lt.26307] [Reference Citation Analysis]
40 Hughes DL, Rice JD, Burton JR, Jin Y, Peterson RA, Ambardekar AV, Pomposelli JJ, Pomfret EA, Kriss MS. Presence of any degree of coronary artery disease among liver transplant candidates is associated with increased rate of post-transplant major adverse cardiac events. Clin Transplant 2020;34:e14077. [PMID: 32939833 DOI: 10.1111/ctr.14077] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lauterio A, De Carlis R, Cannata A, Di Sandro S, De Gasperi A, Russo C, De Carlis L. Emergency Intraoperative Implantation of ECMO for Refractory Cardiogenic Shock Arising During Liver Transplantation as a Bridge to Myocardial Surgical Revascularization. Transplantation 2019;103:e317-8. [DOI: 10.1097/tp.0000000000002826] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Aghaulor B, VanWagner LB. Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation. Clin Liver Dis 2021;25:157-77. [PMID: 33978576 DOI: 10.1016/j.cld.2020.08.008] [Reference Citation Analysis]
43 De Gasperi A, Spagnolin G, Ornaghi M, Petrò L, Biancofiore G. Preoperative cardiac assessment in liver transplant candidates. Best Pract Res Clin Anaesthesiol 2020;34:51-68. [PMID: 32334787 DOI: 10.1016/j.bpa.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Kutkut I, Rachwan RJ, Timsina LR, Ghabril MS, Lacerda MA, Kubal CA, Bourdillon PD, Mangus RS. Pre-Liver Transplant Cardiac Catheterization Is Associated With Low Rate of Myocardial Infarction and Cardiac Mortality. Hepatology 2020;72:240-56. [PMID: 31696952 DOI: 10.1002/hep.31023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
45 Tincopa MA, Weinberg RL, Sengupta S, Slivnick J, Corbett J, Sonnenday CJ, Fontana RJ, Sharma P. The Utility of Noninvasive PET/CT Myocardial Perfusion Imaging in Adult Liver Transplant Candidates. Transplantation Direct 2022;8:e1311. [DOI: 10.1097/txd.0000000000001311] [Reference Citation Analysis]
46 Bernal-Reyes R, Castro-Narro G, Malé-Velázquez R, Carmona-Sánchez R, González-Huezo MS, García-Juárez I, Chávez-Tapia N, Aguilar-Salinas C, Aiza-Haddad I, Ballesteros-Amozurrutia MA, Bosques-Padilla F, Castillo-Barradas M, Chávez-Barrera JA, Cisneros-Garza L, Flores-Calderón J, García-Compeán D, Gutiérrez-Grobe Y, Higuera de la Tijera MF, Kershenobich-Stalnikowitz D, Ladrón de Guevara-Cetina L, Lizardi-Cervera J, López-Cossio JA, Martínez-Vázquez S, Márquez-Guillén E, Méndez-Sánchez N, Moreno-Alcantar R, Poo-Ramírez JL, Ramos-Martínez P, Rodríguez-Hernández H, Sánchez-Ávila JF, Stoopen-Rometti M, Torre-Delgadillo A, Torres-Villalobos G, Trejo-Estrada R, Uribe-Esquivel M, Velarde-Ruiz Velasco JA. The Mexican consensus on nonalcoholic fatty liver disease.Rev Gastroenterol Mex (Engl Ed). 2019;84:69-99. [PMID: 30711302 DOI: 10.1016/j.rgmx.2018.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shamaa O, Jafri SM, Shamaa MT, Brown K, Venkat D. Takotsubo Cardiomyopathy Following Liver Transplantation: A Report of 2 Cases. Transplant Proc 2021;53:239-43. [PMID: 32980136 DOI: 10.1016/j.transproceed.2020.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Koshy AN, Enyati A, Weinberg L, Han HC, Horrigan M, Gow PJ, Ko J, Thijs V, Testro A, Lim HS, Farouque O, Teh AW. Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation. Stroke 2021;52:111-20. [PMID: 33349017 DOI: 10.1161/STROKEAHA.120.031454] [Reference Citation Analysis]
49 Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart Failure and Liver Disease: Cardiohepatic Interactions. JACC Heart Fail. 2019;7:87-97. [PMID: 30553904 DOI: 10.1016/j.jchf.2018.10.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
50 Zardi EM, Giorgi C, Dobrina A, Vecile E, Zardi DM. Analogies and differences between cirrhotic cardiomyopathy and hepatopulmonary syndrome. Med Res Rev 2021;41:739-53. [PMID: 33174630 DOI: 10.1002/med.21755] [Reference Citation Analysis]
51 Doctorian T, Nandkeolyar S, Fearon C, Nayak S, Tryon D, Sakr A, Stoletniy L, De Vera M, Volk M, Abramov D. Utility of Framingham Score for Optimizing Preoperative Evaluation Among Patients Undergoing Liver Transplant Evaluation. Transplant Proc 2021;53:1616-21. [PMID: 33965242 DOI: 10.1016/j.transproceed.2021.02.026] [Reference Citation Analysis]
52 Smith NK, Zerillo J, Schlichting N, Sakai T. Abdominal Organ Transplantation: Noteworthy Literature in 2018. Semin Cardiothorac Vasc Anesth 2019;23:188-204. [DOI: 10.1177/1089253219842655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Mohebali D, Anagnostopoulos AM, Estrada-Roman A, Pavlakis M, Curry MP, Gavin MC. Cardiovascular Risk Assessment in Renal and Liver Transplant Candidates: A Multidisciplinary Institutional Standardized Approach. Cardiol Rev 2019;27:286-92. [PMID: 31584469 DOI: 10.1097/CRD.0000000000000282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Khurmi NS, Chang Y, Eric Steidley D, Singer AL, Hewitt WR, Reddy KS, Moss AA, Mathur AK. Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States: Liver Transplantation. Liver Transpl 2018;24:1398-410. [DOI: 10.1002/lt.25055] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
55 Dehne S, Lund F, Larmann J, Schmidt K, Brenner T, Weigand MA, von Haken R. [Anesthesiological aspects of liver transplantation]. Anaesthesist 2019;68:403-18. [PMID: 31049602 DOI: 10.1007/s00101-019-0595-x] [Reference Citation Analysis]
56 Sandal S, Chen T, Cantarovich M. The Challenges With the Cardiac Evaluation of Liver and Kidney Transplant Candidates. Transplantation 2020;104:251-8. [DOI: 10.1097/tp.0000000000002951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
57 Levy PE, Khan SS, VanWagner LB. Cardiac evaluation of the kidney or liver transplant candidate. Curr Opin Organ Transplant 2021;26:77-84. [PMID: 33315765 DOI: 10.1097/MOT.0000000000000838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Moody WE, Holloway B, Arumugam P, Gill S, Wahid YS, Boivin CM, Thomson LE, Berman DS, Armstrong MJ, Ferguson J, Steeds RP. Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study. J Nucl Cardiol 2020. [PMID: 32394403 DOI: 10.1007/s12350-020-02126-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Zorzi A, Brunetti G, Cardaioli F, D'Arcangelo F, Fabris T, Gambato M, Iliceto S, Martini A, Mattesi G, Peluso C, Polacco M, Sartori C, Lorenzoni G, Feltracco P, Angeli P, Burra P, Cillo U, Pontisso P. Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation. Int J Cardiol 2021;339:219-24. [PMID: 34181996 DOI: 10.1016/j.ijcard.2021.06.046] [Reference Citation Analysis]
60 Koshy AN, Farouque O, Cailes B, Ko J, Han HC, Weinberg L, Testro A, Robertson M, Teh AW, Lim HS, Gow PJ. Prediction of Perioperative Cardiovascular Events in Liver Transplantation. Transplantation 2021;105:593-601. [PMID: 32413014 DOI: 10.1097/TP.0000000000003306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
61 Ward RA, Ajayi T, Aylward T, Byrns J, Summers BB, Wilder J. Multi-disciplinary approach to perioperative risk assessment and post-transplant management for liver transplantation in a patient at risk for Brugada syndrome. Journal of Perioperative Practice 2019;29:140-6. [DOI: 10.1177/1750458918796013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]